Literature DB >> 20473883

Do selective estrogen receptor modulators treat cervical precancer and cancer? Time to pool data from relevant trials.

Philip E Castle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20473883      PMCID： PMC2944904          DOI： 10.1002/ijc.25393

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  15 in total

Review 1.  Surgery for cervical intraepithelial neoplasia.

Authors:  P L Martin-Hirsch; E Paraskevaidis; H Kitchener
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 2.  Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

Authors:  Yongfeng Shang
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

3.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Authors:  Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Scott M Lippman; Carolyn D Runowicz; Patricia A Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Journal:  JAMA       Date:  2006-06-05       Impact factor: 56.272

4.  Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model.

Authors:  Tiffany Brake; Paul F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

5.  Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.

Authors:  Sang-Hyuk Chung; Paul F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

Review 6.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

Review 7.  Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk.

Authors:  Steven R Cummings; Jeffrey A Tice; Scott Bauer; Warren S Browner; Jack Cuzick; Elad Ziv; Victor Vogel; John Shepherd; Celine Vachon; Rebecca Smith-Bindman; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

8.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Authors:  B Fisher; J P Costantino; D L Wickerham; C K Redmond; M Kavanah; W M Cronin; V Vogel; A Robidoux; N Dimitrov; J Atkins; M Daly; S Wieand; E Tan-Chiu; L Ford; N Wolmark
Journal:  J Natl Cancer Inst       Date:  1998-09-16       Impact factor: 13.506

Review 9.  Development of therapeutic HPV vaccines.

Authors:  Cornelia L Trimble; Ian H Frazer
Journal:  Lancet Oncol       Date:  2009-10       Impact factor: 41.316

10.  Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models.

Authors:  Laura L Reimers; William F Anderson; Philip S Rosenberg; Donald E Henson; Philip E Castle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-03       Impact factor: 4.254
View more
  4 in total

1.  Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.

Authors:  Megan E Spurgeon; Johan A den Boon; Mark Horswill; Sonalee Barthakur; Omid Forouzan; Janet S Rader; David J Beebe; Avtar Roopra; Paul Ahlquist; Paul F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

2.  SERMs suppresses the growth of ERα positive cervical cancer xenografts through predominant inhibition of extra-nuclear ERα expression.

Authors:  Balaji Ramachandran; Kanchan Murhekar; Shirley Sundersingh
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

3.  Past and future of prophylactic ablation of the cervical squamocolumnar junction.

Authors:  Silvia Franceschi
Journal:  Ecancermedicalscience       Date:  2015-04-29

4.  Antiestrogen use reduces risk of cervical neoplasia in breast cancer patients: a population-based study.

Authors:  Chia-Jung Hsieh; Mun-Kun Hong; Pau-Chung Chen; Jen-Hung Wang; Tang-Yuan Chu
Journal:  Oncotarget       Date:  2017-04-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.